To read Cereno Scientifics Article of Association, click here
Cereno Scientific identifies possibilities for expanding the use of its treatment concept in cardiovascular diseases
Through its Scientific Advisory Board, Cereno Scientific has identified the...
Cereno Scientific appoints Mangold as Liquidity Provider
Cereno Scientific AB (”Cereno Scientific” or “the Company”) has appointed...
The subscription period for Cereno Scientifics rights issue begins and the Company invites to investor events
Today May 23, 2019, the subscription period for Cereno Scientific’s...
Heart Failure Congress 2019, Athens
2019-05-25 - 2019-05-27
Half-year report 2019
Subscribe for corporate news
Follow us on LinkedIn
Follow us on Twitter
We are proud supporters of World Thrombosis Day. Read more